Oncolab

Cheongju, South Korea

Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.

$684K raised

Nov 2025

Seed

Top Investors

FuturePlay

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oncolab raised?

Oncolab has raised $684K in total funding. The most recent round was Seed. The last funding was announced in November 2025.

Who are Oncolab's investors?

Oncolab's investors include FuturePlay.

Where is Oncolab headquartered?

Oncolab is headquartered in Cheongju, South Korea.

What does Oncolab do?

Oncolab is developing a technology that reduces systemic toxicity and enhances therapeutic efficacy.

What stage is Oncolab at?

Oncolab is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 11, 2025.

MLA

"Oncolab — Funding & Investors." VCBacked, November 11, 2025, https://www.vcbacked.co/company/oncolab. Accessed June 17, 2026.

APA

VCBacked. (2025). Oncolab — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/oncolab

Wikipedia (cite web)

{{cite web |title=Oncolab — Funding & Investors |url=https://www.vcbacked.co/company/oncolab |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 11, 2025.